Fresenius Medical Care AG (ETR:FME – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of €39.72 and traded as high as €41.68. Fresenius Medical Care shares last traded at €40.99, with a volume of 703,707 shares traded.
Fresenius Medical Care Stock Performance
The stock’s 50-day moving average is €41.56 and its 200 day moving average is €39.72. The firm has a market cap of $12.13 billion, a P/E ratio of 18.42, a PEG ratio of 0.42 and a beta of 0.94. The company has a debt-to-equity ratio of 87.31, a quick ratio of 0.80 and a current ratio of 1.07.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
- Five stocks we like better than Fresenius Medical Care
- 3 Unexpected ETFs Crushing the Market This Summer
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
